癌ペプチドワクチン療法中の再燃前立腺癌患者のQOLについて

概要

論文の詳細を見る
The purpose of this study was to clarify QOL of hormone-refractory prostate cancer patient undergoing clinical trial. Extracted contexts from record and information which CRN collected were 1671 items. They were categorized into 3 aspects; physical, psychological and social. As a result, we considered it as follows. 1) The degradation of QOL was not significant in 3～12 months. 2) The most unbearable distress of the patient was a physical pain. Therefore, it is important to carry out the pain control. 3) The mental support is necessary so that the patient keep having hope. 4) The support from the family is important for the patient to have his good life.
九州大学の論文
2004-09-06